MediPines
MediPines Corp: Pioneering advanced respiratory medicine through innovative medical devices.
Founded
2014MediPines Corp: Pioneering advanced respiratory medicine through innovative medical devices.
MediPines Corporation, founded with a mission to revolutionize respiratory medicine, focuses on developing innovative medical devices for advanced respiratory care. The company's flagship product, the MediPines AGM100™, provides fast, accurate, and non-invasive assessments of cardiorespiratory status at the point of care. MediPines aims to enhance diagnostic and treatment decisions in respiratory medicine, targeting healthcare providers and institutions that require precise and timely respiratory evaluations.
Notable figures associated with MediPines include leading experts in respiratory medicine and seasoned medical device professionals. The company has garnered attention from prominent investors in the healthcare technology sector. Key achievements include the successful development and deployment of the AGM100™, which has significantly impacted clinical practices by improving patient outcomes through better diagnostic accuracy. MediPines continues to influence the field of respiratory medicine with its cutting-edge solutions, contributing to advancements in patient care and medical technology.
Companies similar to MediPines include Invent Medical, Respiratory Motion, Respirix and Aero Therapeutics.
MediPines was founded in 2014.
MediPines' headquarters is located in Yorba Linda, CA, US.
MediPines' most recent funding round was for $3.1M (USD) in September 2021.
As of Sep 8, 2021, MediPines has disclosed funding of $7.4M (USD). Undisclosed round amounts are excluded.
MediPines has 19 employees as of Feb 5, 2024.
